ReviewYeast (Chichester, England)2025
The Power of Yeast.
Review in Yeast (Chichester, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Transposon-based genome editing of industrial microorganisms: advances, challenges, and prospects.Synthetic and systems biotechnology · 2026Review
- One Yeast, Sixteen Synthetic Chromosomes, Infinite Possibilities.Yeast (Chichester, England) · 2026Review
- Enhanced Untargeted Metabolomics Based on High-Resolution Mass Spectrometry Reveals Global Rewiring Due to Mitochondrial Dysfunction in Yeast.International journal of molecular sciences · 2026Article
- Systems biology of yeast metabolism.FEMS yeast research · 2026Review
- The Power of Yeast.Yeast (Chichester, England) · 2025Review
- Synthesis of Programmable Bioelectronic Yeast for Biohybrid Futures.Engineering biologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yeasts have been intimately connected with human civilization for millennia, originally used for fermentation in food and beverage production. This article explores the multifaceted roles of yeasts-particularly Saccharomyces cerevisiae-as both a model organism and a cell factory. The historical journey of yeast research is chronicled from early fermentation practices to its central role in the molecular biology revolution. Notable discoveries using yeast have led to numerous Nobel Prizes, demonstrating its power in elucidating fundamental biological processes such as the eukaryal cell cycle, protein trafficking, transcription, and autophagy. The deep conservation of cellular pathways between yeast and humans, such as AMPK/Snf1 and TORC1/Tor1 signaling, further underscores yeast's value in biomedical research. Beyond its use in basic science, S. cerevisiae has become a preferred host for industrial biotechnology due to its genetic tractability, safety status, and ability to scale fermentation processes. Yeast has been engineered to produce a broad range of chemicals, fuels, and pharmaceuticals. Advanced tools in metabolic engineering-including genome-scale metabolic models, multi-omics analyses, and adaptive laboratory evolution-have driven remarkable improvements in yield, productivity, and strain robustness. These tools also offer insights into fundamental metabolic regulation and cellular adaptation. As the article discusses, yeast has not only illuminated the molecular workings of eukaryal life but also transformed industrial biotechnology. Its legacy and continued evolution affirm its indispensable role in science and technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.